These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 35641849)

  • 21. The association between proton pump inhibitor use and the risk of adverse kidney outcomes: a systematic review and meta-analysis.
    Nochaiwong S; Ruengorn C; Awiphan R; Koyratkoson K; Chaisai C; Noppakun K; Chongruksut W; Thavorn K
    Nephrol Dial Transplant; 2018 Feb; 33(2):331-342. PubMed ID: 28339835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Interstitial nephritis].
    Halbritter J; Mayer C; Rasche FM; Amann K; Lindner TH
    Internist (Berl); 2009 Sep; 50(9):1111-25. PubMed ID: 19690821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proton Pump Inhibitors and the Kidney: Implications of Current Evidence for Clinical Practice and When and How to Deprescribe.
    Al-Aly Z; Maddukuri G; Xie Y
    Am J Kidney Dis; 2020 Apr; 75(4):497-507. PubMed ID: 31606235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Azithromycin-Induced, Biopsy-Proven Acute Interstitial Nephritis in an Adult Successfully Treated with Low-Dose Corticosteroids.
    Woodruff AE; Meaney CJ; Hansen EA; Prescott GM
    Pharmacotherapy; 2015 Nov; 35(11):e169-74. PubMed ID: 26598102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association of proton pump inhibitors and chronic kidney disease: cause or confounding?
    Li T; Xie Y; Al-Aly Z
    Curr Opin Nephrol Hypertens; 2018 May; 27(3):182-187. PubMed ID: 29432214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proton Pump Inhibitors and CKD.
    Moledina DG; Perazella MA
    J Am Soc Nephrol; 2016 Oct; 27(10):2926-2928. PubMed ID: 27080978
    [No Abstract]   [Full Text] [Related]  

  • 27. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.
    Lazarus B; Chen Y; Wilson FP; Sang Y; Chang AR; Coresh J; Grams ME
    JAMA Intern Med; 2016 Feb; 176(2):238-46. PubMed ID: 26752337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of corticosteroids during ongoing drug exposure in pantoprazole-induced interstitial nephritis.
    Kim MJ; Heim M; Mayr M
    Nephrol Dial Transplant; 2010 May; 25(5):1716-9. PubMed ID: 20067906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency and etiology of tubulo-interstitial nephritis in an adult renal biopsies in a tertiary renal care hospital: A single-center study.
    Qureshi R; Imtiaz S; Dhrolia M; Ahmad A
    Saudi J Kidney Dis Transpl; 2020; 31(2):335-341. PubMed ID: 32394905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proton pump inhibitors and acute interstitial nephritis: report and analysis of 15 cases.
    Simpson IJ; Marshall MR; Pilmore H; Manley P; Williams L; Thein H; Voss D
    Nephrology (Carlton); 2006 Oct; 11(5):381-5. PubMed ID: 17014549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune checkpoint inhibitor (nivolumab)-associated kidney injury and the importance of recognizing concomitant medications known to cause acute tubulointerstitial nephritis: a case report.
    Koda R; Watanabe H; Tsuchida M; Iino N; Suzuki K; Hasegawa G; Imai N; Narita I
    BMC Nephrol; 2018 Feb; 19(1):48. PubMed ID: 29486725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug-induced nephrotoxicity. Aetiology, clinical features and management.
    Hoitsma AJ; Wetzels JF; Koene RA
    Drug Saf; 1991; 6(2):131-47. PubMed ID: 2043284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adverse Effects Associated with Long-Term Use of Proton Pump Inhibitors.
    Maideen NMP
    Chonnam Med J; 2023 May; 59(2):115-127. PubMed ID: 37303818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prospective study of drug-induced interstitial nephritis in eleven French nephrology units].
    Leven C; Hudier L; Picard S; Longuet H; Lorcy N; Cam G; Boukerroucha Z; Dolley-Hitze T; Le Cacheux P; Halimi JM; Cornec Le Gall E; Hanrotel-Saliou C; Arreule A; Massad M; Duveau A; Couvrat-Desvergnes G; Renaudineau E
    Presse Med; 2014 Nov; 43(11):e369-76. PubMed ID: 25218248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-induced tubulointerstitial nephritis: hypersensitivity and necroinflammatory pathways.
    Eddy AA
    Pediatr Nephrol; 2020 Apr; 35(4):547-554. PubMed ID: 30820701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse outcomes of proton pump inhibitors in patients with chronic kidney disease: The CKD-REIN cohort study.
    Liabeuf S; Lambert O; Metzger M; Hamroun A; Laville M; Laville SM; Frimat L; Pecoits-Filho R; Fouque D; Massy ZA; Jacquelinet C; Stengel B;
    Br J Clin Pharmacol; 2021 Jul; 87(7):2967-2976. PubMed ID: 33368448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Granulomatous tubulointerstitial nephritis secondary to omeprazole.
    Nadri Q; Althaf MM
    BMJ Case Rep; 2014 Oct; 2014():. PubMed ID: 25323274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lansoprazole-induced acute allergic interstitial nephritis in a renal transplant recipient: a case report.
    Yildirim T; Yilmaz R; Baydar DE; Kutlugun AA; Aki T; Turgan C
    Int Urol Nephrol; 2012 Dec; 44(6):1903-6. PubMed ID: 21537857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medication-Induced Interstitial Nephritis in the 21st Century.
    Nast CC
    Adv Chronic Kidney Dis; 2017 Mar; 24(2):72-79. PubMed ID: 28284382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute Interstitial Nephritis and Checkpoint Inhibitor Therapy: Single Center Experience of Management and Drug Rechallenge.
    Manohar S; Ghamrawi R; Chengappa M; Goksu BNB; Kottschade L; Finnes H; Dronca R; Leventakos K; Herrmann J; Herrmann SM
    Kidney360; 2020 Jan; 1(1):16-24. PubMed ID: 35372854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.